About Us‎ > ‎Latest News‎ > ‎

Breaking News!

posted 30 Mar 2017, 07:13 by Alan B.
Don't hold your breath but a new drug has just been approved by the Federal Drugs Authority (FDA) in the United States which may be followed by approval in Europe and Scotland (eventually). Ocrelizumab is an important drug  because not only does it seem to be of benefit for many with Relapse/Remittting MS but also for some with Primary Progressive MS. 

So for the first time there is the prospect of treatment for those with PPMS. It won't work for everyone and there are side effects of course but I think this counts as good news! For more information try the MS Trust website HERE